ARTICLE | Clinical News
Abraxane paclitaxel regulatory update
June 20, 2005 7:00 AM UTC
The partners submitted a marketing application to Health Canada for Abraxane to treat metastatic breast cancer. The solvent-free nanoparticle albumin-bound formulation of paclitaxel was approved in th...